CYP 7.46% 31.0¢ cynata therapeutics limited

Ann: Quarterly Activity Report & Appendix 4C, page-48

  1. 4,056 Posts.
    lightbulb Created with Sketch. 1376
    Hi Varky,

    You can start at looking the company website.

    About Cymerus

    The trademark Cymerus refers to the patented process of generating cell-based products from intermediate cells, known as mesenchymoangioblasts (MCAs), which in turn are derived from induced pluripotent stem cells (iPSCs). This technology was originally developed at the University of Wisconsin-Madison (UWM), a world-renowned leader in stem cell research.

    The means of producing MCAs from pluripotent precursors, and the defining pattern of MCA cell surface markers, are the subjects of US patent 7,615,374, and a number of other patent applications in process around the world, licensed to or owned by Cynata.

    At present, Cynata is focussed on the production of mesenchymal stem cell (MSC)-based products using the Cymerus technology.


    https://www.cynata.com/about-cymerus

    https://www.cynata.com/

    Regards

    Rossi70
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
-0.025(7.46%)
Mkt cap ! $55.68M
Open High Low Value Volume
33.0¢ 33.0¢ 31.0¢ $69.62K 219.4K

Buyers (Bids)

No. Vol. Price($)
2 37054 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 36751 1
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
31.5¢
  Change
-0.025 ( 5.32 %)
Open High Low Volume
33.5¢ 33.5¢ 31.0¢ 58449
Last updated 15.59pm 14/06/2024 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.